Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic? - PubMed

Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic?

Samudi Chandramathi et al. Trans R Soc Trop Med Hyg. 2012 Apr.

Abstract

Chemotherapy can cause immunosuppression, which may trigger latent intestinal parasitic infections in stools to emerge. This study investigated whether intestinal parasites can emerge as opportunistic infections in breast and colorectal cancer patients (n=46 and n=15, respectively) undergoing chemotherapy treatment. Breast cancer patients were receiving a 5-fluorouracil/epirubicin/cyclophosphamide (FEC) regimen (6 chemotherapy cycles), and colorectal cancer patients were receiving either an oxaliplatin/5-fluorouracil/folinic acid (FOLFOX) regimen (12 cycles) or a 5-fluorouracil/folinic acid (Mayo) regimen (6 cycles). Patients had Blastocystis hominis and microsporidia infections that were only present during the intermediate chemotherapy cycles. Thus, cancer patients undergoing chemotherapy should be screened repeatedly for intestinal parasites, namely B. hominis and microsporidia, as they may reduce the efficacy of chemotherapy treatments.

Similar articles

• The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.

  Matsushita H, Tsuboi K, Honda I, Kato N, Okochi O, Kobayashi D, Hattori M. Matsushita H, et al. Gan To Kagaku Ryoho. 2009 May;36(5):797-801. Gan To Kagaku Ryoho. 2009. PMID: 19461180

• Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group.

  Bonneterre J, Roché H, Kerbrat P, Fumoleau P, Goudier MJ, Fargeot P, Montcuquet P, Clavère P, Barats JC, Monnier A, Veyret C, Datchary J, Van Praagh I, Chapelle-Marcillac I. Bonneterre J, et al. J Clin Oncol. 2004 Aug 1;22(15):3070-9. doi: 10.1200/JCO.2004.03.098. J Clin Oncol. 2004. PMID: 15284257 Clinical Trial.

• OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.

  Tournigand C, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M, Mineur L, Carola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, André T, Tabah-Fisch I, de Gramont A. Tournigand C, et al. J Clin Oncol. 2006 Jan 20;24(3):394-400. doi: 10.1200/JCO.2005.03.0106. J Clin Oncol. 2006. PMID: 16421419 Clinical Trial.

• Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.

  Ottosson S, Magnusson K, Hultborn R. Ottosson S, et al. Anticancer Res. 1999 Sep-Oct;19(5C):4429-34. Anticancer Res. 1999. PMID: 10650787

• Chemotherapy of metastatic colorectal cancer.

  [No authors listed] [No authors listed] Prescrire Int. 2010 Oct;19(109):219-24. Prescrire Int. 2010. PMID: 21180382 Review.

Cited by

• Exacerbation of colon carcinogenesis by Blastocystis sp.

  Kumarasamy V, Kuppusamy UR, Jayalakshmi P, Samudi C, Ragavan ND, Kumar S. Kumarasamy V, et al. PLoS One. 2017 Aug 31;12(8):e0183097. doi: 10.1371/journal.pone.0183097. eCollection 2017. PLoS One. 2017. PMID: 28859095 Free PMC article.

• Colorectal cancer and Blastocystis sp. infection.

  Sulżyc-Bielicka V, Kołodziejczyk L, Adamska M, Skotarczak B, Jaczewska S, Safranow K, Bielicki P, Kładny J, Bielicki D. Sulżyc-Bielicka V, et al. Parasit Vectors. 2021 Apr 14;14(1):200. doi: 10.1186/s13071-021-04681-x. Parasit Vectors. 2021. PMID: 33853659 Free PMC article.

• Are Blastocystis hominis and Cryptosporidium spp. playing a positive role in colorectal cancer risk? A systematic review and meta-analysis.

  Taghipour A, Rayatdoost E, Bairami A, Bahadory S, Abdoli A. Taghipour A, et al. Infect Agent Cancer. 2022 Jun 17;17(1):32. doi: 10.1186/s13027-022-00447-x. Infect Agent Cancer. 2022. PMID: 35715853 Free PMC article. Review.

• Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.

  Rajamanikam A, Kumar S, Samudi C, Kudva M. Rajamanikam A, et al. Parasitol Res. 2018 Aug;117(8):2585-2590. doi: 10.1007/s00436-018-5948-x. Epub 2018 Jun 5. Parasitol Res. 2018. PMID: 29872961

• Genotyping of Enterocytozoon bieneusi and Subtyping of Blastocystis in Cancer Patients: Relationship to Diarrhea and Assessment of Zoonotic Transmission.

  Zhang W, Ren G, Zhao W, Yang Z, Shen Y, Sun Y, Liu A, Cao J. Zhang W, et al. Front Microbiol. 2017 Sep 21;8:1835. doi: 10.3389/fmicb.2017.01835. eCollection 2017. Front Microbiol. 2017. PMID: 28983297 Free PMC article.

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information